Michel Sadelain, Carl June receive 2024 Breakthrough Prize in Life Sciences

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

On May 30, an international coalition announced the launch of CAR T Vision, a coalition that aims to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy.

May 30, 2025

Vol.51 No.21

In Brief

KU Cancer Center breaks ground for new complex

The University of Kansas Cancer Center broke ground on the future site of a new complex on May 22 that will bring research and patient care into one area for the first time in KU Cancer Center’s history.

May 30, 2025

Vol.51 No.21

In Brief

Intermountain Health to expand stem cell collection for CAR-T cell therapy, bringing procedure to southern Utah

Intermountain Health is now offering a national expansion of CAR-T cell therapy, bringing cancer care closer to patients in southern Utah and Nevada.

May 16, 2025

Vol.51 No.19

Rewriting the rules of cancer treatment one nanobody at a time

I joined Translational Genomics Research Institute, part of City of Hope, late last year to launch the Center for Accelerated Nanotherapeutics.

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.

Diane Reidy-Lagunes appointed chief of medical oncology at Duke

Diane Reidy-Lagunes joined Duke University School of Medicine’s Department of Medicine as chief of the Division of Medical Oncology, effective April 1.

May 02, 2025

Vol.51 No.17

Michel Sadelain, Carl June receive 2024 Breakthrough Prize in Life Sciences

YOU MAY BE INTERESTED IN

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

KU Cancer Center breaks ground for new complex

Intermountain Health to expand stem cell collection for CAR-T cell therapy, bringing procedure to southern Utah

Rewriting the rules of cancer treatment one nanobody at a time

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Diane Reidy-Lagunes appointed chief of medical oncology at Duke

Renew today!

Subscriber content

Never miss an issue!

Login